Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_assertion type Assertion NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_head.
- NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_assertion description "[In 34 cases where MSP results were available, MGMT promoter hypermethylation was detected in five cases (14.7%) with mucinous or clear cell carcinomas, but not in any of other histological types (P = 0.031).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_provenance.
- NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_assertion evidence source_evidence_literature NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_provenance.
- NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_assertion SIO_000772 21450028 NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_provenance.
- NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_assertion wasDerivedFrom befree-20140225 NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_provenance.
- NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_assertion wasGeneratedBy ECO_0000203 NP356101.RAbKilk4gHnPSPi12ex-f-XMdCfIj3T8E4uCPlhFa38tM130_provenance.